Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)
| 1.57 Delayed Data As of May 27 |  +0.02 / +1.29%Today’s Change | 1.29 Today|||52-Week Range 8.50 | -66.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 76.0K | 72.0K | 100.0K | 107.0K | ||
| Operating Expenses | Gross Income | -76.0K | -72.0K | -100.0K | -107.0K | |
| General Expenses | 12.2M | 15.2M | 17.6M | 18.5M | ||
| Research And Development | 8.9M | 11.8M | 14.4M | 14.8M | ||
| Total Operating Expenses | 12.2M | 15.3M | 17.7M | 18.6M | ||
| Non-Operating Expenses | Operating Income | -12.2M | -15.3M | -17.7M | -18.6M | |
| Other Expenses | -13.0K | -20.0K | -17.0K | -16.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -11.9M | -14.9M | -17.2M | -18.0M | |
| Net Income | -11.9M | -14.9M | -17.2M | -18.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 22.0M | 24.0M | 29.0M | 32.8M | |
| Shares To Calculate EPS Diluted | 22.0M | 24.0M | 29.0M | 32.8M | ||
| Earnings Per Share | EPS | -$0.54 | -$0.62 | -$0.59 | -$0.55 | |
| EPS Diluted | -$0.54 | -$0.62 | -$0.59 | -$0.55 | ||
